Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126722151 | 12672215 | 1 | I | 20150805 | 20160804 | 20160822 | 20160822 | EXP | PHHY2016IN108815 | NOVARTIS | 59.00 | YR | F | Y | 0.00000 | 20160822 | MD | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126722151 | 12672215 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, Q12MO | 21817 | 5 | MG | SOLUTION FOR INJECTION | |||||||
| 126722151 | 12672215 | 2 | C | THYROXIN | LEVOTHYROXINE | 1 | Oral | 12.5 MG, QD (2 OR 3 YEARS BACK) | 0 | 12.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126722151 | 12672215 | 1 | Osteoporosis |
| 126722151 | 12672215 | 2 | Thyroid disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126722151 | 12672215 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126722151 | 12672215 | Drug ineffective | |
| 126722151 | 12672215 | Fall | |
| 126722151 | 12672215 | Femur fracture | |
| 126722151 | 12672215 | Lower limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126722151 | 12672215 | 1 | 20150805 | 0 |